pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Cambridge biologist David Sabatini awarded $6 million after jury rejects harassment claims

Oct 19, 2026·read at STAT ↗Positive

David Sabatini, a former MIT and Whitehead Institute researcher, faced allegations of inappropriate conduct from a younger colleague, leading to his removal from the institute.

A Suffolk County jury recently awarded Sabatini $6 million in damages in his civil lawsuit against the accuser, while dismissing her claims that he retaliated or harassed her.

Sabatini described the years following his ouster as the hardest of his life, and he said the court decision marks a significant personal vindication.

The case highlights the legal challenges that can arise from workplace disputes in academic research settings.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Cambridge scientist David Sabatini speaks out after courtroom victory: ‘The hardest years of my life’”

read at STAT ↗
402 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING
topics
ApprovalOncologyPeptide Therapeutic

related stories

  • 3d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Sep 145 drugmakers chasing Merck and Moderna in the cancer vaccine raceBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 1The hidden history of BPC-157, a favorite MAHA peptideSTAT
  • Jun 18STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and moreSTAT